Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol mebutate gel 0.015% repeat use for multiple actinic keratoses on face and scalp
2011-005018-13Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Apr 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of ingenol mebutate in actinic keratosis (AK), sponsored by LEO Pharma. Started Apr 2012; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2011-005018-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005018-13.